Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Centuria Office REIT (COF.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (A$) Price Target (A$) Rating
2022-02-282.242.25Sell
2022-06-171.70-No Rating
2022-06-201.731.81Neutral
2022-08-021.701.76Neutral
2022-12-191.621.70Neutral
2023-02-021.761.75Neutral
2023-06-211.441.60Buy
2023-08-181.321.50Buy
2023-12-201.351.35Neutral
2024-07-051.151.19Neutral
2024-08-151.221.10Sell
2024-09-241.241.14Sell
2025-04-011.14-No Rating
2025-04-021.161.14Sell

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.